SPR Therapeutics' wins $1.6M NIH grant for pain relief system: 4 quick facts

Spinal Tech

The National Institute on Aging, of the National Institutes of Health, has given SPR Therapeutics a $1.6 million grant.

Here are four quick facts:

 

1. The grant will be used to advance clinical research related to its non-narcotic pain management system for knee replacement surgery patients.

 

2. SPR Therapeutics' SPRINT peripheral nerve stimulation system is designed to provide pain relief by stimulating nerves in the leg using a fine wire, or lead, that is temporarily implanted.

 

3. The FDA approved an investigational device exemption study to examine the safety and effectiveness of the system. Data from this clinical trial will be used to support U.S. regulatory clearance and commercialization.

 

4. The grant award coincides with SPR Therapeutics' recently initiated convertible debt offering and upcoming Series B equity financing.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers